How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
Market Commentary: 2 Deals This Billionaire Is Scooping Up
David Einhorn, the esteemed founder of Greenlight Capital, is widely recognized for making a killing during the Great Recession when he shorted the market. Nowadays, the investment world is curious about where Einhorn finds potential in the current market, particularly which stocks in his portfolio are poised for significant growth.
Read More
1 No-Brainer Stock to Buy Now with $360
If you were going to buy just one stock, you would want it to have some key characteristics, and among the best is a share price that increases with the market but holds steady when markets fall.
In 2022 when the market fell by 20%, Berkshire Hathaway treaded water, essentially beating the market by 20%.
» Read more about: 1 No-Brainer Stock to Buy Now with $360 »
Read More
1 AI Stock To Avoid In 2024
The story and hype around artificial intelligence drove a whole wave of technology stocks higher in 2023. Some of the gains were well-deserved and others, like Broadcom, might have mushroomed to unsustainable levels for 2024.
We took a peek at the financials to see if the current valuation matches with the price and,
» Read more about: 1 AI Stock To Avoid In 2024 »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
Will New Buffett Buy 10x?
Last year, Warren Buffett surprised practically everyone when he acquired more than 30% of embattled internet radio giant Sirius XM (NASDAQ:SIRI).
At first, Buffett appeared to be taking advantage of an arbitrage opportunity, but subsequent purchases have suggested that the Oracle of Omaha is more interested in building a long-term position in Sirius XM.
» Read more about: Will New Buffett Buy 10x? »
Read MoreThe Spotlight
Is This Beverage Titan Paying 6.17% at Rock Bottom?
Ambev is a monster $32.9 billion company with an extensive portfolio of beer, soft drinks, and beverages. Although it has a significant market presence in Latin America, particularly in Brazil, Argentina, and Mexico, it may be best known for operating as part of Anheuser-Busch InBev, the world’s largest brewer.
The company owns some of the most recognizable beer brands in the world,
» Read more about: Is This Beverage Titan Paying 6.17% at Rock Bottom? »
Read MoreThe Daily
Social Security cost-of-living adjustment for 2026 is projected to be lowest in recent years. Why that may change
- New government data shows the pace of inflation has subsided from pandemic-era highs.
- Consequently, Social Security beneficiaries may see a smaller annual cost-of-living adjustment in 2026.
- But experts say two developing factors — tariffs and prescription drug prices — may impact seniors’ budgets.
The Social Security cost-of-living adjustment for 2026 is on pace to be the lowest annual benefit increase in five years,